Editorial Note: The Viterra digestion is the trade. Bunge swallowed Viterra in July 2025 and revenue immediately doubled to ~$22B/qtr — but margins crashed because two giant grain traders are still being stitched together. Management is openly telling you the model: $15 mid-cycle EPS by 2030. At $125 today, that's a 3x earnings power story IF integration sticks. The 100% earnings beat rate suggests they're sandbagging guidance. The catch: FCF is negative, insiders are selling, and the soybean cycle could roll over before the synergies print.

The Story Right Now

Bunge is the boring agribusiness name nobody on FinTwit is pumping — which is exactly what makes it interesting in a market saturated with AI-infra rotation chasers. The setup: a 200-year-old company merged with a $50B-revenue Glencore-owned grain trader (Viterra) in July 2025, and the combined entity is now mid-digestion. Q1 2026 revenue hit $21.86B — 88% YoY growth — but gross margin compressed from 5.1% to 3.5% and EPS dropped from $1.48 to $0.35. The market sees the margin crater and shrugs.

The thesis hinges on the management roadmap they laid out 2026-03-10: $15 mid-cycle EPS by 2030. That's not a stretch goal; it's roughly what the pre-merger combined entity earned at peak. At $125 today on TTM EPS of ~$4.29 (Q2'25 + Q3'25 + Q4'25 + Q1'26 = $2.61 + $0.84 + $0.49 + $0.35), the stock trades at ~29x TTM. But TTM is artificially compressed by integration costs. Mid-cycle: $125/$15 = 8.3x forward — cheap for an irreplaceable grain-merchandising network with 50+ countries of physical infrastructure.

Where this fits our system: BG is the food-security peer to ADM (already in our food-security watchlist), and it sits in the cascade chain from Iran war perspective (geopolitical premium on grain logistics). It also surfaced 3x in 2026-Q1 monster-scans before pulling back. The 100% earnings beat rate over recent quarters tells you management is calibrated; the negative FCF and -$4.4M insider selling tells you the integration isn't done. The right shape is: stage in slowly on weakness, watch for gross margin recovery above 5% sustained, and let the operating-leverage story play out 2026-2027.

The contrarian angle vs the rotation cluster we've been screening: while every paid-signals account is pumping AI-infra baskets and rare-earth lottery tickets, BG is a real-physical-infrastructure name with a clear roadmap and no FOMO. That's the kind of setup that compounds without being noticed. Discount: it's also a commodity cyclical, so a soybean price collapse + dollar strength + Brazilian crop surge would gut the thesis.

Quick Snapshot

Action Matrix

Entry zone: $115–$125 (current $124.94, accept on shallow pullback) Stop-loss: $100 (-20% from current) Target: $165 (+32% from current)

Price Data

Company Overview

Bunge Global SA — premier agribusiness solutions company, founded 1818, headquartered in Chesterfield MO, listed NYQ as BG.

• Market cap: $24.2B
• Employees: 34,000
• Operations: 50+ countries
• Website: bunge.com

Four operating segments:

This is one of the four ABCD grain trading giants (ADM, Bunge, Cargill, Louis Dreyfus). With Viterra absorbed, BG is now arguably the #2 global grain trader by volume.

Recent Financials

Income Statement Trend (8 quarters)

The pattern is stark. Pre-merger (Q2 2024 – Q1 2025) revenue ~$11.6–13.5B/qtr at 5–8% gross margin and 0.6–4.7% op margin. Post-Viterra-close (Q3 2025 onward) revenue jumps to $22–24B/qtr but margins compress to 3.5–4.8% gross and 0.3–0.8% operating. The merger doubled the revenue base but added lower-margin grain-trading volume that hasn't been integrated to capture synergies yet.

TTM EPS: $2.61 + $0.84 + $0.49 + $0.35 = $4.29 → P/E ≈ 29x at $124.94. Pre-merger run-rate (4 quarters: Q2'24–Q1'25): $0.48 + $1.56 + $4.36 + $1.48 = $7.88 → implied normalized P/E ≈ 16x. Mid-cycle target ($15): P/E ≈ 8.3x — implies ~3x earnings power if guidance hits.

Balance Sheet (latest)

Manageable leverage given the asset base; Viterra deal added significant debt but D/E < 1 keeps it within investment-grade territory.

Cash Flow (latest quarter)

Negative FCF is the bear-case anchor. Driven by working-capital build during merger integration + ongoing capex. Should normalize as Viterra digestion completes — but until then, the company is consuming cash, not generating it.

Quality Checks

Short Interest

Moderate short interest. 58% short-volume ratio is elevated and suggests active hedging or pair trades (likely vs. ADM).

Dividend

• Last amount: $0.72/share
• Frequency: quarterly
• Last ex-date: 2027-02-16 (NOTE: this is a future date in the data — likely calendar quirk; treat as ~$2.88 annualized = ~2.3% yield at $125)

Bull Case

1. Viterra integration synergies materialize. Management guided $15 mid-cycle EPS by 2030. Even at 12x forward P/E (below historical), that's $180/share. From $125, that's a 44% return over ~4 years (~10% IRR), and history says ag-cyclicals overshoot to upside when synergies print.
2. 100% earnings beat rate. Recent quarters consistently beat. Suggests management is sandbagging guidance — the surprises are likely to be upside, not down.
3. Soybean oil → biodiesel cascade. $2.35B cooking-oil-recycling market, expanding biodiesel mandates. BG's soybean processing is a direct beneficiary. Renewable-diesel demand structurally rising regardless of crude oil price.
4. Food-security geopolitical premium. With Iran war perspective live and grain-route disruption a recurring theme, physical-grain-merchandiser networks (50+ country footprint) become strategic infrastructure. ADM/BG/Cargill/LDC are the only credible Western grain-logistics operators at scale.
5. Cyclical bottom on margins. Q1 2026 gross margin 3.5% is the lowest in the 8-quarter dataset. Mean-reversion alone gets them back to 5–6% over the next 4 quarters — that flows directly to EPS multiplier given high op-leverage.
6. Network irreplaceability. 200 years of operating history, 34K employees, 50+ countries of facilities. You cannot rebuild this with capital alone. Monopolistic infrastructure layer at the bottom of the food-supply pyramid.

Bear Case

1. Margin compression doesn't recover. Viterra synergies could take 3–4 years instead of 1–2. If gross margins stay below 5% through 2027, EPS stays at $4–5 range and the multiple compresses further. Stock could re-rate to $80–100.
2. Negative cash flow + high debt = no flexibility. $-723M FCF in Q1 Operating cash flow −$541M in Q1 (correction 2026-08-03, D038 class: the "−$723M FCF" was OCF −$541M plus the entire −$182M investing line — the investing-CF-as-capex substitution; BG's true capex is uncached, so FCF is unverifiable, but OCF alone is genuinely negative) + $11.3B LT debt means any cyclical downturn hurts disproportionately. If commodity prices crater, BG can't easily de-lever.
3. Insider selling. Net -$4.4M (1 buy, 3 sells). Insiders aren't accumulating at these levels — that's not bullish even if ratios are small relative to the stock.
4. Soybean cycle risk. Brazil + Argentina mega-harvests + dollar strength = soybean price collapse scenario. ADM/BG margins compress further; net income could turn negative.
5. Ag-input peer FMC is at -67% from highs. Suggests something is breaking in the broader ag-chem complex; not necessarily contagious to oilseed crush, but worth watching.
6. Revenue acceleration is -15.3%. Even though YoY is +88% (merger-distorted), QoQ momentum is decelerating. If Q2 2026 prints below Q1's $21.86B, the merger-bump narrative cracks.

Risk Factors (from 10-K, 2026-02-19 filing)

• Adverse weather / climate change — drought, hurricanes, severe storms historically caused crop failures and operational disruption.
• Transportation disruption — relies on ocean vessels, river barges, rail, trucks. Low-river-level events (Mississippi droughts) have hit operations historically.
• Commodity price volatility — direct exposure to soybean, corn, wheat, palm oil, sugar, etc. Sharp price moves compress margins on both sides.
• Geopolitical / trade-policy — tariffs (US-China soybean trade is the canonical example) and export bans have repeatedly disrupted the business.
• Regulatory — biofuels mandates, food-safety regs, climate disclosures, foreign-investment review of cross-border M&A.

Thesis Killers

• Gross margin stays below 4% for 4 consecutive quarters → integration is failing
• Net income turns negative for any quarter → capital structure stress
• $15 mid-cycle EPS guidance is walked back at investor day → management lost confidence
• Soybean price drops below $9/bu → cyclical bottom isn't in

Catalysts

Recent News

Cross-References

• food-security watchlist — added 2026-05-10
• monster-discoveries watchlist — appears in monster-scan history
• Recurring monster-scan hits across March 12, March 26, and March 31 2026

Related Tickers to Monitor

Entry Strategy

• Conviction: Medium (per playbook: 3–5% allocation max)
• Stage in: Don't chase. Buy 1/3 at $122–125, 1/3 at $115–118 if pullback, 1/3 at $108–112 if deeper.
• Stop: $100 (just below 52wk-low $71.60 mean-reversion floor + post-merger panic-floor)
• First target: $135 (re-test of 52wk high — partial trim on test)
• Mid-cycle target: $165 (~13x normalized $12 EPS or 11x mid-cycle $15)
• Multi-year target: $200+ if Viterra synergies print fully and ag-cycle turns

What Would Change the Verdict

• Upgrade to high conviction: Q2 2026 gross margin >5%, FCF turns positive, and management reaffirms $15 EPS roadmap with milestones.
• Downgrade to low / exit: Q2 2026 gross margin <3.5%, net income negative, or insider selling accelerates above $20M net.

Open Questions

• What's the actual Viterra synergy schedule? Get the M&A presentation deck and trace milestones.
• Is there a renewable-diesel mandate update timeline (US EPA + EU RED III) that could be a 2026-H2 catalyst?
• How does BG's soybean-meal export book compare to ADM's? Any market-share gain post-Viterra?
• Is the 5.5M short interest a pair trade vs ADM? Worth checking 13F overlap.
• CBOT soybean futures at what level? Need to get into the cyclical context.

Sources

• Massive (Polygon) — company info, news, financials (8 quarters), short interest, dividends, 10-K
• Tavily — supplementary news + research
• yfinance — OHLC + 52-week range
• Benzinga 2026-03-10 — $15 mid-cycle EPS guidance article (canonical source for the thesis)
• StockStory 2026-04-15 — Research report
• MarketBeat 2026-04-06 — 52wk-high context

Research Log